Detalhe da pesquisa
1.
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
Lancet
; 392(10152): 1058-1070, 2018 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30177236
2.
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
Lancet
; 390(10093): 480-489, 2017 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619476
3.
Brexanolone as adjunctive therapy in super-refractory status epilepticus.
Ann Neurol
; 82(3): 342-352, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779545
4.
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
Hum Psychopharmacol
; 32(2)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370307
5.
Brexanolone injection for post-partum depression treatment - Authors' reply.
Lancet
; 394(10196): 380, 2019 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31255299
6.
Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose.
Clin Pharmacokinet
; 61(9): 1307-1319, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869362
7.
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.
Clin Pharmacokinet
; 59(1): 111-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338688